OP04 Vedolizumab intravenous is effective across multiple treatment targets in chronic pouchitis: Results of the randomised, double-blind, placebo-controlled EARNEST trialSimon Travis, Bo Shen, Silvio Danese et al.|Journal of Crohn s and Colitis|2022Cited by 11